Modern Management of Chronic Venous Insufficiency
Andrew W. Bradbury
doaj +1 more source
Minimally invasive management of chronic venous insufficiency: A case report on combined radiofrequency ablation and sclerotherapy in an obese patient. [PDF]
La Marca MA +5 more
europepmc +1 more source
A prospective study on hyperhomocysteinemia as an aggravating factor in chronic venous insufficiency. [PDF]
Rotaru M, Mariana Iancu G, Baldovin I.
europepmc +1 more source
This review presents a process‐oriented framework for vascularized cardiac tissue engineering, highlighting how the coordinated design of cells, biomaterials, and biofabrication strategies enables the functional development or vascularized myocardium for disease modelling and drug discovery.
Yang Liu +9 more
wiley +1 more source
Nutritional Status in a Group of Patients with Wounds Due to Diabetic Foot Disease and Chronic Venous Insufficiency. [PDF]
Skórka M +5 more
europepmc +1 more source
Case Report: Successful results of direct varicose vein ablation with EVLA in chronic venous insufficiency patient in Indonesia. [PDF]
Taofan T +7 more
europepmc +1 more source
This study designs a targeted nanocomposite (ct@HMCF‐Dex) that responds to acidic infection microenvironments, releasing components which amplify oxidative stress. It disrupts bacterial redox balance, chelates metals to sustain lipid peroxidation, and synergistically induces cuproptosis/ferroptosis‐like death.
Zehui Xiao +6 more
wiley +1 more source
The Effect of Inelastic Compression Wraps on the Quality of Life of People with Chronic Venous Insufficiency: A Single-Center, Single-Arm, Prospective Study. [PDF]
Smits AH +3 more
europepmc +1 more source
Concentrations of selected acute phase proteins in patients with chronic venous insufficiency treated with Sulodexide. Part 1. [PDF]
Kaczmarek B +5 more
europepmc +1 more source
In a single‐center cohort of 577 adult LDLT recipients who underwent simultaneous splenectomy, clinically significant SFSS grade B/C (ILTS‐iLDLT‐LTSI 2023) occurred in 18.2% and was associated with inferior graft survival. Multivariate analysis identified MELD ≥ 30, NLR ≥ 4.5, and donor age ≥ 50 years as independent risk factors, which risk rising ...
Kyohei Yugawa +6 more
wiley +1 more source

